Key statistics
As of last trade Akeso Inc (4RY:STU) traded at 8.65, -2.26% below its 52-week high of 8.85, set on Nov 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.65 |
---|---|
High | 8.65 |
Low | 8.65 |
Bid | 8.75 |
Offer | 9.05 |
Previous close | 8.85 |
Average volume | 0.00 |
---|---|
Shares outstanding | 897.56m |
Free float | 668.34m |
P/E (TTM) | -- |
Market cap | 64.80bn HKD |
EPS (TTM) | -0.9414 HKD |
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Press releases
- Summit Therapeutics Reports Operational Progress and Financial Results for the Third Quarter and Nine Months Ended September 30, 2024
- Summit Therapeutics to Host Third Quarter 2024 Financial Results & Operational Progress Call on October 30, 2024
- Summit Therapeutics Announces Completion of Enrollment in Its Phase III HARMONi Trial in 2L+ EGFRm NSCLC
- Promising Anti-Tumor Activity and Safety of Ivonescimab in Combination Therapies in CRC, TNBC, and HNSCC Featured at ESMO 2024
- Summit Therapeutics Raises $235 Million
- Ivonescimab Monotherapy Reduced the Risk of Disease Progression or Death by 49% Compared to Pembrolizumab Monotherapy in First-Line Treatment of Patients with PD-L1 Positive Advanced NSCLC in China
More ▼